Loading...
Bienvenue dans la collection HAL Infinity
Recherche en Immunologie, Inflammation et Maladies Infectieuses : du fondamental au translationnel
L’Institut Toulousain des Maladies Infectieuses et Inflammatoires (Infinity), créé au 1er janvier 2021, résulte de la fusion de deux unités de recherche localisées sur le campus Purpan, le Centre de Physiopathologie Toulouse Purpan (CPTP) et l’Unité de Différenciation Epithéliale et Autoimmunité Rhumatoïde (UDEAR).
Nombre de fichiers déposés
822
Dernières publications
-
Rémi Nguyen Van, Pauline Houssel‐debry, Domitille Erard, Jérôme Dumortier, Anne Pouvaret, et al.. Characteristics, management, and outcome of tuberculosis after liver transplant: a case series and literature review. Infectious Diseases Now, 2024, Infectious Diseases Now, 54 (3), pp.104869. ⟨10.1016/j.idnow.2024.104869⟩. ⟨hal-04483646⟩
-
Damien Caillet Portillo, Xavier Puéchal, Maëva Masson, Marie Kostine, Alexia Michaut, et al.. Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registry. Journal of Infection, 2024, 88 (2), pp.132-138. ⟨10.1016/j.jinf.2023.12.010⟩. ⟨hal-04495049⟩
-
Joanna Kedra, Philippe Dieudé, Caroline Giboin, Hubert Marotte, Carine Salliot, et al.. Towards the lowest efficacious dose (ToLEDo): results of a multicenter non‐inferiority randomized open‐label controlled trial assessing Tocilizumab or Abatacept injection spacing in rheumatoid arthritis in remission. Arthritis & rheumatology, 2024, ⟨10.1002/art.42752⟩. ⟨hal-04279434⟩
Nombre de notices déposée
935
Taux d'open access
75 %
Sujets
Cytomegalovirus
Extracellular vesicles
IgE
Biomarkers
Cholesterol
Immune response
Atopic dermatitis
Macrophage
Skin
Liver transplantation
Immunosuppression
COVID-19
Female
Ribavirin
Dupilumab
Infectious disease
Dendritic cells
Dog
Treatment
SARS-CoV-2
Pregnancy
Signaling
Monocyte
Actin cytoskeleton
Anophthalmia
Lipids
Infection
HIV-1
HIV
NK cells
Obesity
Prevention
Children
Hepatitis E
Allergy
Immunotherapy
Malaria
Filaggrin
Omicron
Outcome
Cytokines
Escherichia coli
Thymus
Immunology
Placenta
Ant-CCP
Autoimmunity
Congenital infection
Autoantibodies
T lymphocytes
Humans
Cancer
Autoimmune diseases
Mutation
Psoriasis
Immunological synapse
Diagnosis
Toxoplasma gondii
Cameroon
Apoptosis
Public health
Lymphocytes
Antigen presentation
Prevalence
Regulatory T cells
Organ transplantation
Staphylococcus aureus
Oxidative stress
Kidney transplantation
Asthma
Epidermis
Prader-Willi syndrome
Differentiation
Chronic kidney disease
Multiple sclerosis
Age
Hepatitis E virus
Plasmodium falciparum
Rheumatoid arthritis
Safety
Male
AIDS
Risk factors
Metabolism
Macrophages
Microphthalmia
Systemic lupus erythematosus
T cells
Preeclampsia
Transplantation
Anaphylaxis
Statistical model
Epidemiology
Vaccine
Mast cells
France
Mast cell
Inflammation
ACPA
Innate immunity